Literature DB >> 20109446

Transgenic BDNF induces nerve fiber regrowth into the auditory epithelium in deaf cochleae.

Seiji B Shibata1, Sarah R Cortez, Lisa A Beyer, James A Wiler, Adriana Di Polo, Bryan E Pfingst, Yehoash Raphael.   

Abstract

Sensory organs typically use receptor cells and afferent neurons to transduce environmental signals and transmit them to the CNS. When sensory cells are lost, nerves often regress from the sensory area. Therapeutic and regenerative approaches would benefit from the presence of nerve fibers in the tissue. In the hearing system, retraction of afferent innervation may accompany the degeneration of auditory hair cells that is associated with permanent hearing loss. The only therapy currently available for cases with severe or complete loss of hair cells is the cochlear implant auditory prosthesis. To enhance the therapeutic benefits of a cochlear implant, it is necessary to attract nerve fibers back into the cochlear epithelium. Here we show that forced expression of the neurotrophin gene BDNF in epithelial or mesothelial cells that remain in the deaf ear induces robust regrowth of nerve fibers towards the cells that secrete the neurotrophin, and results in re-innervation of the sensory area. The process of neurotrophin-induced neuronal regeneration is accompanied by significant preservation of the spiral ganglion cells. The ability to regrow nerve fibers into the basilar membrane area and protect the auditory nerve will enhance performance of cochlear implants and augment future cell replacement therapies such as stem cell implantation or induced transdifferentiation. This model also provides a general experimental stage for drawing nerve fibers into a tissue devoid of neurons, and studying the interaction between the nerve fibers and the tissue. Copyright (c) 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109446      PMCID: PMC2864331          DOI: 10.1016/j.expneurol.2010.01.011

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  68 in total

Review 1.  Latest development in viral vectors for gene therapy.

Authors:  Kenneth Lundstrom
Journal:  Trends Biotechnol       Date:  2003-03       Impact factor: 19.536

2.  BDNF-induced survival of auditory neurons in vivo: Cessation of treatment leads to accelerated loss of survival effects.

Authors:  Lisa N Gillespie; Graeme M Clark; Perry F Bartlett; Phillip L Marzella
Journal:  J Neurosci Res       Date:  2003-03-15       Impact factor: 4.164

3.  Gene transfer into supporting cells of the organ of Corti.

Authors:  Shin-ichi Ishimoto; Kohei Kawamoto; Sho Kanzaki; Yehoash Raphael
Journal:  Hear Res       Date:  2002-11       Impact factor: 3.208

Review 4.  Auditory system development: primary auditory neurons and their targets.

Authors:  Edwin W Rubel; Bernd Fritzsch
Journal:  Annu Rev Neurosci       Date:  2002-02-05       Impact factor: 12.449

Review 5.  The molecular architecture of the inner ear.

Authors:  Andrew Forge; Tony Wright
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

6.  Hair cell protection from aminoglycoside ototoxicity by adenovirus-mediated overexpression of glial cell line-derived neurotrophic factor.

Authors:  M Yagi; E Magal; Z Sheng; K A Ang; Y Raphael
Journal:  Hum Gene Ther       Date:  1999-03-20       Impact factor: 5.695

7.  Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.

Authors:  Andrew K Wise; Rachael Richardson; Jennifer Hardman; Graeme Clark; Stephen O'leary
Journal:  J Comp Neurol       Date:  2005-06-27       Impact factor: 3.215

Review 8.  Making and breaking the innervation of the ear: neurotrophic support during ear development and its clinical implications.

Authors:  B Fritzsch; U Pirvola; J Ylikoski
Journal:  Cell Tissue Res       Date:  1999-03       Impact factor: 5.249

Review 9.  Therapeutic potential of neurotrophins for treatment of hearing loss.

Authors:  W Q Gao
Journal:  Mol Neurobiol       Date:  1998       Impact factor: 5.590

10.  Neurotrophin-3 transduction attenuates cisplatin spiral ganglion neuron ototoxicity in the cochlea.

Authors:  William J Bowers; Xiaowei Chen; Huang Guo; D Robert Frisina; Howard J Federoff; Robert D Frisina
Journal:  Mol Ther       Date:  2002-07       Impact factor: 11.454

View more
  58 in total

1.  Hyaluronic acid enhances gene delivery into the cochlea.

Authors:  Seiji B Shibata; Sarah R Cortez; James A Wiler; Donald L Swiderski; Yehoash Raphael
Journal:  Hum Gene Ther       Date:  2012-02-08       Impact factor: 5.695

2.  AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.

Authors:  Patricia A Leake; Stephen J Rebscher; Chantale Dore'; Omar Akil
Journal:  J Assoc Res Otolaryngol       Date:  2019-06-20

3.  Across-site patterns of modulation detection: relation to speech recognition.

Authors:  Soha N Garadat; Teresa A Zwolan; Bryan E Pfingst
Journal:  J Acoust Soc Am       Date:  2012-05       Impact factor: 1.840

4.  Conditioning the cochlea to facilitate survival and integration of exogenous cells into the auditory epithelium.

Authors:  Yong-Ho Park; Kevin F Wilson; Yoshihisa Ueda; Hiu Tung Wong; Lisa A Beyer; Donald L Swiderski; David F Dolan; Yehoash Raphael
Journal:  Mol Ther       Date:  2014-01-07       Impact factor: 11.454

Review 5.  Importance of cochlear health for implant function.

Authors:  Bryan E Pfingst; Ning Zhou; Deborah J Colesa; Melissa M Watts; Stefan B Strahl; Soha N Garadat; Kara C Schvartz-Leyzac; Cameron L Budenz; Yehoash Raphael; Teresa A Zwolan
Journal:  Hear Res       Date:  2014-09-28       Impact factor: 3.208

6.  Chronic neurotrophin delivery promotes ectopic neurite growth from the spiral ganglion of deafened cochleae without compromising the spatial selectivity of cochlear implants.

Authors:  Thomas G Landry; James B Fallon; Andrew K Wise; Robert K Shepherd
Journal:  J Comp Neurol       Date:  2013-08-15       Impact factor: 3.215

7.  How electrically evoked compound action potentials in chronically implanted guinea pigs relate to auditory nerve health and electrode impedance.

Authors:  Kara C Schvartz-Leyzac; Deborah J Colesa; Christopher J Buswinka; Andrew M Rabah; Donald L Swiderski; Yehoash Raphael; Bryan E Pfingst
Journal:  J Acoust Soc Am       Date:  2020-12       Impact factor: 1.840

8.  Selective hair cell ablation and noise exposure lead to different patterns of changes in the cochlea and the cochlear nucleus.

Authors:  Takaomi Kurioka; Min Young Lee; Amarins N Heeringa; Lisa A Beyer; Donald L Swiderski; Ariane C Kanicki; Lisa L Kabara; David F Dolan; Susan E Shore; Yehoash Raphael
Journal:  Neuroscience       Date:  2016-07-09       Impact factor: 3.590

9.  Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy.

Authors:  Yohei Takada; Lisa A Beyer; Donald L Swiderski; Aubrey L O'Neal; Diane M Prieskorn; Shaked Shivatzki; Karen B Avraham; Yehoash Raphael
Journal:  Hear Res       Date:  2013-12-12       Impact factor: 3.208

Review 10.  The use of neurotrophin therapy in the inner ear to augment cochlear implantation outcomes.

Authors:  Cameron L Budenz; Bryan E Pfingst; Yehoash Raphael
Journal:  Anat Rec (Hoboken)       Date:  2012-10-08       Impact factor: 2.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.